These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 6951505

  • 1. In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Thompson RL, Fisher KA, Wenzel RP.
    Antimicrob Agents Chemother; 1982 Feb; 21(2):341-3. PubMed ID: 6951505
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci.
    Cynamon MH, Granato PA.
    Chemotherapy; 1982 Feb; 28(3):204-8. PubMed ID: 6212205
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
    Brown JE, Del Bene VE, Collins CD.
    Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci.
    Sachdeva M, Hackbarth C, Stella FB, Chambers HF.
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1549-52. PubMed ID: 3481245
    [Abstract] [Full Text] [Related]

  • 13. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
    Braveny I, Machka K, Elsser R.
    Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
    [Abstract] [Full Text] [Related]

  • 14. Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.
    Neu HC, Labthavikul P.
    Antimicrob Agents Chemother; 1982 Jan; 21(1):180-7. PubMed ID: 6979306
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.
    Horadam VW, Smilack JD, Montgomery CL, Werringloer J.
    Antimicrob Agents Chemother; 1980 Oct; 18(4):557-61. PubMed ID: 6934707
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
    Miller MA, LeFrock JL, Vercler MJ.
    Microbiol Immunol; 1981 Oct; 25(11):1119-27. PubMed ID: 6276701
    [Abstract] [Full Text] [Related]

  • 18. Activity of eleven antimicrobial agents against methicillin-, methicillin- and rifampin-resistant Staphylococcus aureus.
    Chokkavelu V, Chandrasekar P, Rolston K, LeFrock JL, Schell RF.
    Chemotherapy; 1984 Oct; 30(2):97-101. PubMed ID: 6559665
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Graninger W, Leitha T, Havel M, Georgopoulos A.
    Infection; 1984 Oct; 12(4):293-5. PubMed ID: 6092279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.